BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15280532)

  • 1. Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.
    Wu Z; Alexandratos J; Ericksen B; Lubkowski J; Gallo RC; Lu W
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11587-92. PubMed ID: 15280532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.
    Scarlata S; Ehrlich LS; Carter CA
    J Mol Biol; 1998 Mar; 277(2):161-9. PubMed ID: 9514761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma.
    Matthews S; Barlow P; Boyd J; Barton G; Russell R; Mills H; Cunningham M; Meyers N; Burns N; Clark N
    Nature; 1994 Aug; 370(6491):666-8. PubMed ID: 8065455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mother-infant HIV type 1 gag p17 sequences associated with perinatal transmission.
    Hahn T; Matala E; Chappey C; Ahmad N
    AIDS Res Hum Retroviruses; 1999 Jul; 15(10):875-88. PubMed ID: 10408724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entropic switch regulates myristate exposure in the HIV-1 matrix protein.
    Tang C; Loeliger E; Luncsford P; Kinde I; Beckett D; Summers MF
    Proc Natl Acad Sci U S A; 2004 Jan; 101(2):517-22. PubMed ID: 14699046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions.
    Perez-Caballero D; Hatziioannou T; Martin-Serrano J; Bieniasz PD
    J Virol; 2004 Sep; 78(17):9560-3. PubMed ID: 15308748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of HIV-1 Gag myristoylation on membrane binding.
    Provitera P; El-Maghrabi R; Scarlata S
    Biophys Chem; 2006 Jan; 119(1):23-32. PubMed ID: 16183191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV-1 p17 matrix protein is transported into the cell nucleus and binds with genomic viral RNA].
    Bukrinskaia AG; Vorkunova GK; Tentsov IuIu
    Mol Biol (Mosk); 1993; 27(1):49-57. PubMed ID: 8483474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.
    Barros M; Heinrich F; Datta SAK; Rein A; Karageorgos I; Nanda H; Lösche M
    J Virol; 2016 May; 90(9):4544-4555. PubMed ID: 26912608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p17 stretch at the N terminus of the HIV1-gag precursor and the intracellular part of HIV1-env gp41 have heptad repeat regions in their sequences that could bind to each other in a coiled coil.
    Wachinger G; Nitschko H; Wachinger M; von der Helm K
    Protein Seq Data Anal; 1991 Dec; 4(6):375-6. PubMed ID: 1812494
    [No Abstract]   [Full Text] [Related]  

  • 12. Human Polycomb group EED protein negatively affects HIV-1 assembly and release.
    Rakotobe D; Tardy JC; André P; Hong SS; Darlix JL; Boulanger P
    Retrovirology; 2007 Jun; 4():37. PubMed ID: 17547741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of the HIV-1 matrix protein p17.
    Fiorentini S; Marini E; Caracciolo S; Caruso A
    New Microbiol; 2006 Jan; 29(1):1-10. PubMed ID: 16608119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
    J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane relocation but not tight binding of human immunodeficiency virus type 1 Gag particles myristoylated in Escherichia coli.
    Morikawa Y; Kinoshita A; Goto T; Tomoda H; Sano K
    Virology; 2001 May; 283(2):343-52. PubMed ID: 11336559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.
    Caccuri F; Giagulli C; Reichelt J; Martorelli D; Marsico S; Bugatti A; Barone I; Rusnati M; Guzman CA; Dolcetti R; Caruso A
    J Virol; 2014 May; 88(10):5706-17. PubMed ID: 24623414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.
    Henderson LE; Bowers MA; Sowder RC; Serabyn SA; Johnson DG; Bess JW; Arthur LO; Bryant DK; Fenselau C
    J Virol; 1992 Apr; 66(4):1856-65. PubMed ID: 1548743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.
    Sato A; Yoshimoto J; Isaka Y; Miki S; Suyama A; Adachi A; Hayami M; Fujiwara T; Yoshie O
    Virology; 1996 Jun; 220(1):208-12. PubMed ID: 8659115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 matrix protein p17 resides in cell nuclei in association with genomic RNA.
    Bukrinskaya AG; Vorkunova GK; Tentsov YYu
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1795-801. PubMed ID: 1457192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HIV-1 assembly is initiated by p17 matrix protein].
    Vorkunova GK; Lupandin SI; Bukrinskaia AG
    Mol Biol (Mosk); 2011; 45(5):879-83. PubMed ID: 22393785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.